NY-based art collector and active angel investor with a portfolio of over 90 companies including several art-related businesses.
Led the MBO of Camden Motors Limited from Barclays Bank in 1996 and as CEO built the business into one of the largest independently owned Automotive groups in the UK.
Michael Murphy MBE
An experienced angel investor, business leader and non-executive director, Michael Murphy has over 20 years’ board experience and has achieved successful exits in five founder-run businesses.
Philip Mould OBE
Director of Philip Mould & Co one of UK's foremost authorities on British Art and the Old Masters and presenter of BBC's 'Fake or Fortune?'.
Tom Toumazis MBE
Highly experienced media executive and avid art collector, ex-Endemol, Disney, and Yahoo.
With over 12 years in the art world and the expertise in the area of both online and physical art market, Aino has held senior roles in Christie's and Paddle8.
Tagsmart Co-Founder and globally renowned frame-maker, with over 20 years’ experience working with artists, galleries and collectors.
Executive Chairman of Amigo Technology and entrepreneur with a 25-year track record of founding, building and selling analytical technology businesses.
His practice areas cover Commercial Law, Employment Law and Business Immigration Law. He is also part of the cross-disciplinary practice providing advice to FinTech companies on regulatory matters.
Former MD of Goldman Sachs, active art collector and Trustee of the Royal Academy of the Arts.
Leading conservator and art printer. He is responsible for conservation of works by leading contemporary and classical artists from Picasso to Hirst and Hockney.
Professor John Watts
Leading authority on surface chemistry focused on adhesive bonding and nano-materials for paints and adhesives. Director of Research of Materials Science at the University of Surrey.
Dr Carinna Parraman
Prof. in Design and Colour Print at the UWE Bristol and Co-Director of the Centre for Fine Print Research. Pioneers new print and ink techniques for leading artists.
Dr Matthew Baker
World leading synthetic DNA pioneer, CSO at Abzena and Co-Founder of Antitope. His work combines targeted immunotherapy for cancer and autoimmune diseases with DNA-security applications.
Sign up to receive our latest news, opportunities and updates.